OUE Healthcare Limited (SGX:5WA)
Singapore
· Delayed Price · Currency is SGD 0.0240
+0.0010 (4.35%)
At close: Mar 26, 2025
OUE Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 150.28 | 159.32 | 119.8 | 19.67 | 19.98 | Upgrade
|
| Revenue Growth (YoY) | -5.67% | 32.99% | 509.18% | -1.58% | 1.69% | Upgrade
|
| Cost of Revenue | 36.11 | 37.59 | 18.19 | 5.09 | 4.82 | Upgrade
|
| Gross Profit | 114.17 | 121.73 | 101.61 | 14.57 | 15.17 | Upgrade
|
| Selling, General & Admin | 29.47 | 30.88 | 23.51 | 12.24 | 15.45 | Upgrade
|
| Other Operating Expenses | 8.56 | -2.27 | -0.54 | -1.05 | -0.34 | Upgrade
|
| Operating Expenses | 38.03 | 28.61 | 22.98 | 11.19 | 15.11 | Upgrade
|
| Operating Income | 76.14 | 93.12 | 78.63 | 3.39 | 0.05 | Upgrade
|
| Interest Expense | -28.42 | -26.55 | -19.27 | -3.95 | -10.19 | Upgrade
|
| Interest & Investment Income | 0.68 | 0.7 | 0.46 | 0.26 | 0.3 | Upgrade
|
| Earnings From Equity Investments | 1.28 | 1.69 | -1.47 | 12.65 | -39.17 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.09 | -3.74 | -1.1 | -0.09 | 1.05 | Upgrade
|
| EBT Excluding Unusual Items | 42.6 | 65.22 | 57.24 | 12.25 | -47.97 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.83 | -0.75 | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -1.8 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 3.14 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.2 | - | -0.71 | - | - | Upgrade
|
| Asset Writedown | -3.11 | 9.3 | -10.13 | -19.89 | -52.3 | Upgrade
|
| Legal Settlements | 1.3 | - | 1.02 | 6.69 | - | Upgrade
|
| Other Unusual Items | - | - | - | 109.97 | - | Upgrade
|
| Pretax Income | 40.59 | 74.52 | 49.74 | 108.28 | -102.07 | Upgrade
|
| Income Tax Expense | 14.94 | 17.01 | 17.24 | -2.67 | -2.87 | Upgrade
|
| Earnings From Continuing Operations | 25.65 | 57.51 | 32.5 | 110.95 | -99.19 | Upgrade
|
| Net Income to Company | 25.65 | 57.51 | 32.5 | 110.95 | -99.19 | Upgrade
|
| Minority Interest in Earnings | -31.65 | -49.46 | -28.1 | 0.43 | 0.47 | Upgrade
|
| Net Income | -6 | 8.05 | 4.39 | 111.38 | -98.73 | Upgrade
|
| Net Income to Common | -6 | 8.05 | 4.39 | 111.38 | -98.73 | Upgrade
|
| Net Income Growth | - | 83.27% | -96.06% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 4,443 | 4,443 | 4,443 | 4,443 | 4,443 | Upgrade
|
| Shares Outstanding (Diluted) | 4,443 | 7,152 | 7,152 | 6,603 | 4,443 | Upgrade
|
| Shares Change (YoY) | -37.87% | - | 8.32% | 48.60% | - | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | 0.00 | 0.03 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | 0.00 | 0.02 | -0.02 | Upgrade
|
| EPS Growth | - | 83.33% | -96.45% | - | - | Upgrade
|
| Free Cash Flow | 60.11 | 65.05 | 51.01 | 3.14 | -0.36 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Gross Margin | 75.97% | 76.41% | 84.82% | 74.11% | 75.90% | Upgrade
|
| Operating Margin | 50.67% | 58.45% | 65.64% | 17.23% | 0.26% | Upgrade
|
| Profit Margin | -4.00% | 5.05% | 3.67% | 566.38% | -494.12% | Upgrade
|
| Free Cash Flow Margin | 40.00% | 40.83% | 42.58% | 15.95% | -1.79% | Upgrade
|
| EBITDA | 78.41 | 93.58 | 79.1 | 4.27 | 0.6 | Upgrade
|
| EBITDA Margin | 52.18% | 58.74% | 66.03% | 21.71% | 3.01% | Upgrade
|
| D&A For EBITDA | 2.27 | 0.46 | 0.47 | 0.88 | 0.55 | Upgrade
|
| EBIT | 76.14 | 93.12 | 78.63 | 3.39 | 0.05 | Upgrade
|
| EBIT Margin | 50.67% | 58.45% | 65.64% | 17.23% | 0.26% | Upgrade
|
| Effective Tax Rate | 36.81% | 22.82% | 34.66% | - | - | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.